Skip to content

13F-HR filed by Avidity Partners Management LP

Avidity Partners Management LP filed this 13F-HR for the quarter ended 2021-12-31, filed 2022-02-14, with 97 holding rows worth $4,714,958,000.

Accession
0001791827-22-000002
Filed
2022-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2021

A holdings report, 97 entries on the cover page, a total value of $4,714,958,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $4,714,958,000 with VALUE read as thousands by filing date, 13F file number 028-20028. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
AbbVie,Inc.00287Y109COM1,985,000$268,769,000thousands by filing date
ZENTALIS PHARMACEUTICALS INC98943L107COMMON STOCK2,715,000$228,223,000thousands by filing date
ARVINAS INC04335A105COM2,527,973$207,648,000thousands by filing date
AVANTOR INC COM05352A100Stock4,792,000$201,935,000thousands by filing date
ASTRAZENECA PLC SPONSORED ADR046353108ADR2,867,200$167,014,000thousands by filing date
BIOHAVEN PHARMACEUTICAL HOLDING11196105COM1,140,000$157,103,000thousands by filing date
BAXTER INTL INC071813109COM1,765,000$151,508,000thousands by filing date
Elevance Health, Inc.036752103COM321,000$148,796,000thousands by filing date
Pfizer Inc.717081103COM2,090,000$123,415,000thousands by filing date
MIRATI THERAPEUTICS INC60468T105COM806,400$118,291,000thousands by filing date
IVERIC BIO INC46583P102COM6,955,000$116,288,000thousands by filing date
UNITED THERAPEUTICS CORP DEL COM91307C102Stock535,000$115,603,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW1,215,500$112,969,000thousands by filing date
HORIZON THERAPEUTICS PLCG46188101SHS1,012,000$109,053,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM1,260,000$107,314,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM995,000$106,574,000thousands by filing date
SEAGEN INC81181C104COM685,000$105,901,000thousands by filing date
SYNDAX PHARMACEUTICALS INC87164F105COM4,823,400$105,584,000thousands by filing date
Eli Lilly and Company532457108COM344,800$95,241,000thousands by filing date
CATALENT INC USD 0.01148806102COM695,000$88,981,000thousands by filing date
NATERA INC COM632307104Stock940,000$87,787,000thousands by filing date
HOLOGIC INC436440101COM1,064,000$81,460,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM3,780,000$72,160,000thousands by filing date
SOTERA HEALTH CO83601L102COM2,960,000$69,708,000thousands by filing date
NUVATION BIO INC COM CL A67080N101Stock7,382,488$62,751,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock370,000$62,745,000thousands by filing date
UnitedHealth Group Inc91324P102COM123,100$61,813,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM280,000$61,488,000thousands by filing date
IDEAYA BIOSCIENCES INC COM45166A102Stock2,553,000$60,353,000thousands by filing date
ULTRAGENYX PHARMACEUTICAL IN90400D108COM700,000$58,863,000thousands by filing date
ARROWHEAD PHARMACEUTICALS IN04280A100COM875,000$58,013,000thousands by filing date
STEVANATO GROUP S P A ORD SHST9224W109Stock2,541,893$57,065,000thousands by filing date
GRITSTONE BIO INC39868T105COM4,370,000$56,198,000thousands by filing date
KEZAR LIFE SCIENCES INC49372L100COM3,228,200$53,976,000thousands by filing date
ADICET BIO INC007002108COM3,034,004$53,065,000thousands by filing date
AVIDITY BIOSCIENCES INC COM05370A108Stock1,815,000$43,143,000thousands by filing date
KYMERA THERAPEUTICS INC501575104COM670,000$42,538,000thousands by filing date
IMMUNOCORE HLDGS PLC ADS45258D105ADR1,230,000$42,115,000thousands by filing date
CARIBOU BIOSCIENCES INC COM142038108Stock2,674,067$40,352,000thousands by filing date
INSMED INC COM PAR $.01457669307Stock1,450,000$39,498,000thousands by filing date
ORTHO CLINICAL DIAGNOSTICS HG6829J107ORD SHS1,790,000$38,288,000thousands by filing date
PHATHOM PHARMACEUTICALS INC71722W107COMMON STOCK1,896,000$37,294,000thousands by filing date
ESSA PHARMA INC29668H708COM NEW2,460,000$34,932,000thousands by filing date
AMN HEALTHCARE SVCS INC001744101COM280,100$34,265,000thousands by filing date
LEGEND BIOTECH CORP52490G102SPONSORED ADS711,900$33,182,000thousands by filing date
ALPHATEC HLDGS INC02081G201COM NEW2,773,000$31,695,000thousands by filing date
BELLUS HEALTH INC NEW07987C204COM3,775,000$30,389,000thousands by filing date
VIR BIOTECHNOLOGY INC92764N102COM700,000$29,309,000thousands by filing date
AXSOME THERAPEUTICS INC. COM05464T104Stock775,000$29,280,000thousands by filing date
SEASPINE HLDGS CORP81255T108COM2,010,000$27,376,000thousands by filing date
ALTIMMUNE INC02155H200COM NEW2,765,000$25,327,000thousands by filing date
VIRIDIAN THERAPEUTICS INC92790C104COM1,278,261$25,271,000thousands by filing date
GLOBAL BLOOD THERAPEUTICS USD37890U108COM862,000$25,231,000thousands by filing date
CHEMOCENTRYX INC16383L106COM644,400$23,463,000thousands by filing date
SI BONE INC825704109COM987,400$21,930,000thousands by filing date
CYTEIR THERAPEUTICS INC23284P103COMMON1,849,538$21,029,000thousands by filing date
ALPINE IMMUNE SCIENCES INC02083G100COM1,345,000$18,628,000thousands by filing date
RELMADA THERAPEUTICS INC75955J402COMMON STOCK731,536$16,482,000thousands by filing date
SCYNEXIS INC811292200COM NEW2,239,278$13,660,000thousands by filing date
CENTURY THERAPEUTICS INC15673T100COM851,522$13,505,000thousands by filing date
PHASEBIO PHARMACEUTICALS INC717224109COM4,405,000$11,497,000thousands by filing date
HYPERFINE INC44916K106Common Stock1,514,410$10,979,000thousands by filing date
SENTINELONE INC81730H109CL A208,000$10,502,000thousands by filing date
GRAPHITE BIO INC38870X104COM710,000$8,825,000thousands by filing date
FIELD TRIP HEALTH LTD31656R102COM3,205,000$7,884,000thousands by filing date
TANGO THERAPEUTICS INC87583X109COM705,000$7,713,000thousands by filing date
ACADIA PHARMACEUTICALS INC004225108COM300,000$7,002,000thousands by filing date
Instil Bio, Inc.45783C101Common Stock408,140$6,983,000thousands by filing date
TALARIS THERAPEUTICS INC87410C104COM455,037$6,958,000thousands by filing date
DEFINITIVE HEALTHCARE CORP24477E103CLASS A COM250,000$6,833,000thousands by filing date
EQRX INC26886C107COM1,000,000$6,820,000thousands by filing date
CAREMAX INC14171W103COM827,402$6,354,000thousands by filing date
COMPASS THERAPEUTICS INC20454B104COM2,000,000$6,340,000thousands by filing date
MONTE ROSA THERAPEUTICS INC61225M102COM300,000$6,126,000thousands by filing date
WEREWOLF THERAPEUTICS INC95075A107CMN485,000$5,776,000thousands by filing date
MEDICUS SCIENCES ACQUISITIONG5960S108CL A SHS520,000$5,039,000thousands by filing date
ARYA SCIENCES ACQU CORP IVG31659108COM500,000$4,958,000thousands by filing date
DYNAMICS SPECIAL PURPOSE COR268010105CLASS A COM500,000$4,930,000thousands by filing date
SCIENCE 37 HOLDINGS INC808644108COM394,000$4,913,000thousands by filing date
BCLS ACQUISITION CORPG0904B105CMN500,000$4,900,000thousands by filing date
PANACEA ACQUISITION CORP IIG6882C106COM500,000$4,850,000thousands by filing date
ENTRADA THERAPEUTICS INC COM29384C108Stock255,000$4,366,000thousands by filing date
SEMA4 HOLDINGS CORP81663L101COM950,000$4,237,000thousands by filing date
HEALTH SCIENCES ACQ CORP 2G4411D109ORD SHS400,000$4,032,000thousands by filing date
MOONLAKE IMMUNOTHERAPEUTICSG4444C102COM400,000$3,956,000thousands by filing date
SOMALOGIC INC83444K105COM330,000$3,841,000thousands by filing date
MERUS N VN5749R100COM103,000$3,275,000thousands by filing date
ONCOSEC MED INC68234L306COM2,945,000$2,826,000thousands by filing date
SOCIAL CAP SUVRETTA HLDS CRPG8253T106CLASS A ORD SHS200,000$1,986,000thousands by filing date
SOCIAL CAP SUVRETTA HLD CRPIG8253W109CMN200,000$1,980,000thousands by filing date
SOCIAL CAP SUVRETTA HLDS CRPG8253U103CMN200,000$1,978,000thousands by filing date
SOCIAL CAP SUVRETTA HLDS CPG8253Y105CLASS A ORD SHS200,000$1,964,000thousands by filing date
SHATTUCK LABS INC82024L103COMMON STOCK165,000$1,404,000thousands by filing date
ZIOPHARM ONCOLOGY INC98973P101COM590,000$643,000thousands by filing date
SOMALOGIC INC83444k113WT65,999$220,000thousands by filing date
NUVATION BIO INC67080N119WARR99,999$189,000thousands by filing date
MEDICUS SCIENCES ACQUISITIONG5960S124*W EXP 02/12/20257,770$42,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001791827-22-000002this filing2022-02-14acceptance time not in the bulk data set